Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Immunol ; 38(8): 917-926, 2018 11.
Article in English | MEDLINE | ID: mdl-30470982

ABSTRACT

The results of hematopoietic stem cell transplant (HSCT) for primary immunodeficiency diseases (PID) have been improving over time. Unfortunately, developing countries do not experience the same results. This first report of Brazilian experience of HSCT for PID describes the development and results in the field. We included data from transplants in 221 patients, performed at 11 centers which participated in the Brazilian collaborative group, from July 1990 to December 2015. The majority of transplants were concentrated in one center (n = 123). The median age at HSCT was 22 months, and the most common diseases were severe combined immunodeficiency (SCID) (n = 67) and Wiskott-Aldrich syndrome (WAS) (n = 67). Only 15 patients received unconditioned transplants. Cumulative incidence of GVHD grades II to IV was 23%, and GVHD grades III to IV was 10%. The 5-year overall survival was 71.6%. WAS patients had better survival compared to other diseases. Most deaths (n = 53) occurred in the first year after transplantation mainly due to infection (55%) and GVHD (13%). Although transplant for PID patients in Brazil has evolved since its beginning, we still face some challenges like delayed diagnosis and referral, severe infections before transplant, a limited number of transplant centers with expertise, and resources for more advanced techniques. Measures like newborn screening for SCID may hasten the diagnosis and ameliorate patients' conditions at the moment of transplant.


Subject(s)
Graft vs Host Disease/epidemiology , Hematopoietic Stem Cell Transplantation , Immunologic Deficiency Syndromes/therapy , Rare Diseases/therapy , Brazil/epidemiology , Delayed Diagnosis , Developing Countries , Female , Graft vs Host Disease/mortality , Humans , Immunologic Deficiency Syndromes/epidemiology , Immunologic Deficiency Syndromes/mortality , Infant , Infant, Newborn , Male , Neonatal Screening , Rare Diseases/epidemiology , Rare Diseases/mortality , Survival Analysis
2.
Vet Parasitol ; 226: 22-5, 2016 Aug 15.
Article in English | MEDLINE | ID: mdl-27514877

ABSTRACT

Calotropis procera is among the species of medicinal plants that have traditionally been used for the treatment of parasites in small ruminants, stimulating the scientific validation of anthelmintic effects. This study aimed to investigate the chemical composition of ethyl acetate extract of Calotropis procera latex (EAECPL), assess the in vitro effect against Haemonchus contortus and the structural changes caused in the adult worm. The latex was collected, lyophilized and subjected to washing with the ethyl acetate solvent to obtain EAECPL. The constituents of the extract were isolated by column chromatography and identified by (13)C and (1)H nuclear magnetic resonance spectroscopy. The egg hatching test (EHT), larval development test (LDT) and adult worms motility test (WMT) were conducted to evaluate the effectiveness of EAECPL on eggs, larvae and adult of H. contortus, respectively. The worms obtained from the WMT, after 24h exposure to EAECPL or controls were observed on a scanning electron microscope (SEM). The results were analysed by variance analysis and compared with Tukey's test (P<0.05). Three compounds were isolated from EAECPL and identified as urs-19(29)-en-3-yl acetate, (3ß)-Urs-19(29)-en-3-ol, and 1-(2',5'-dimethoxyphenyl)-glycerol. In the EHT, EAECPL inhibited larval hatching by 91.8% at dose of 4mg/ml. In the LDT 1mg/ml inhibited 99.8% larval development. In the WMT, EAECPL in the concentration of 100µg/ml inhibited 100% motility of worms, 12h post-exposition. In the SEM, obvious differences were not detected between the negative control worms and the worms treated with EAECPL. In this study, EAECPL showed an effect on inhibition egg hatching, larval development and motility of the adult worms of H. contortus. This should be related both to the identified compounds, as well as the other compounds present in the EAECPL, acting alone or synergistically.


Subject(s)
Calotropis/chemistry , Haemonchiasis/veterinary , Haemonchus/drug effects , Latex/chemistry , Latex/pharmacology , Abomasum/parasitology , Acetates , Animals , Feces/parasitology , Freeze Drying/veterinary , Haemonchiasis/drug therapy , Haemonchiasis/parasitology , Haemonchus/growth & development , Haemonchus/physiology , Haemonchus/ultrastructure , Magnetic Resonance Spectroscopy , Microscopy, Electron, Scanning/veterinary , Parasite Egg Count/veterinary , Plant Extracts/chemistry , Plant Extracts/pharmacology , Sheep , Sheep Diseases/drug therapy , Sheep Diseases/parasitology
SELECTION OF CITATIONS
SEARCH DETAIL
...